GSK will be back in the acquisition game, CEO says

05/10/2010 | Bloomberg

GlaxoSmithKline, which has abandoned five potential deals since October, is working on two small acquisitions, CEO Andrew Witty said. "We've done very few deals between October last year and the last couple of weeks because we saw a number of companies, but we couldn't get to a price that made sense for our shareholders," Witty said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care